BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Wang Y, Li S, Cui Y, Liang X, Shan J, Gu W, Qiu J, Li Y, Wang G. Functionalized nanoparticles with monocyte membranes and rapamycin achieve synergistic chemoimmunotherapy for reperfusion-induced injury in ischemic stroke. J Nanobiotechnology 2021;19:331. [PMID: 34674712 DOI: 10.1186/s12951-021-01067-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Z, Xia Q, Ma D, Wang Z, Li L, Han M, Yin X, Ji X, Wang S, Xin T. Biomimetic nanoparticles in ischemic stroke therapy. Nanoscale Res Lett 2023;18:40. [DOI: 10.1186/s11671-023-03824-6] [Reference Citation Analysis]
2 Toljan K, Ashok A, Labhasetwar V, Hussain MS. Nanotechnology in Stroke: New Trails with Smaller Scales. Biomedicines 2023;11:780. [DOI: 10.3390/biomedicines11030780] [Reference Citation Analysis]
3 Li J, Wei Y, Zhang C, Bi R, Qiu Y, Li Y, Hu B. Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases. Pharmaceutics 2023;15. [PMID: 36839943 DOI: 10.3390/pharmaceutics15020621] [Reference Citation Analysis]
4 Yu Q, Jian Z, Yang D, Zhu T. Perspective insights into hydrogels and nanomaterials for ischemic stroke. Front Cell Neurosci 2022;16:1058753. [PMID: 36761147 DOI: 10.3389/fncel.2022.1058753] [Reference Citation Analysis]
5 Farhoudi M, Sadigh-Eteghad S, Farjami A, Salatin S. Nanoparticle and Stem Cell Combination Therapy for the Management of Stroke. Curr Pharm Des 2023;29:15-29. [PMID: 36515043 DOI: 10.2174/1381612829666221213113119] [Reference Citation Analysis]
6 Tiwari AK, Gupta PS, Prasad M, Malairajan P. Modulation of Inula racemosa Hook Extract on Cardioprotection by Ischemic Preconditioning in Hyperlipidaemic Rats. J Pharmacopuncture 2022;25:369-81. [PMID: 36628345 DOI: 10.3831/KPI.2022.25.4.369] [Reference Citation Analysis]
7 Chatterjee S, Harini K, Girigoswami A, Nag M, Lahiri D, Girigoswami K. Nanodecoys: A Quintessential Candidate to Augment Theranostic Applications for a Plethora of Diseases. Pharmaceutics 2022;15. [PMID: 36678701 DOI: 10.3390/pharmaceutics15010073] [Reference Citation Analysis]
8 Lui A, Vanleuven J, Perekopskiy D, Liu D, Xu D, Alzayat O, Elgokhy T, Do T, Gann M, Martin R, Liu DZ. FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders. Pharmaceuticals (Basel) 2022;15. [PMID: 36558997 DOI: 10.3390/ph15121546] [Reference Citation Analysis]
9 Li Y, Wang H, Jin J, Yang C, Hu J, Li J. Advances in the research of nano delivery systems in ischemic stroke. Front Bioeng Biotechnol 2022;10:984424. [DOI: 10.3389/fbioe.2022.984424] [Reference Citation Analysis]
10 Xu H, Li S, Liu YS. Nanoparticles in the diagnosis and treatment of vascular aging and related diseases. Signal Transduct Target Ther 2022;7:231. [PMID: 35817770 DOI: 10.1038/s41392-022-01082-z] [Reference Citation Analysis]